US2012200410A1PendingUtilityA1

Analyte Monitoring and Management Device and Method to Analyze the Frequency of User Interaction with the Device

65
Assignee: TAUB MARC BPriority: Jun 29, 2007Filed: Apr 16, 2012Published: Aug 9, 2012
Est. expiryJun 29, 2027(~1 yrs left)· nominal 20-yr term from priority
G06Q 50/22G16H 40/67G16H 10/60A61B 5/14546A61B 5/14532G16H 80/00A61B 5/7275A61B 5/7282A61B 5/746
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and Devices to monitor the level of at least one analyte are provided.

Claims

exact text as granted — not AI-modified
1 . A method, comprising:
 monitoring a user's actual frequency of interaction with the medical device;   comparing the user's actual frequency of interaction with the medical device to at least one predetermined target level of interaction; and   alerting the user when the user's actual frequency of interaction with the medical device is equal to or below the at least one predetermined target level of interaction.   
     
     
         2 . The method of  claim 1 , wherein alerting the user indicates a difference between the actual frequency of interaction with the medical device and the predetermined target level of interaction. 
     
     
         3 . The method of  claim 1 , wherein the user is alerted by an audible alarm. 
     
     
         4 . The method of  claim 3 , wherein the audible alarm increases in loudness over time after being activated. 
     
     
         5 . The method of  claim 1 , wherein the user is alerted by a vibrating alarm. 
     
     
         6 . The method of  claim 1 , further comprising a plurality of predetermined target levels of interaction, wherein alerting the user distinguishes between the plurality of target levels of interaction. 
     
     
         7 . The method of  claim 1 , wherein the user is required to perform at least one step to turn off the alert. 
     
     
         8 . The method of  claim 7 , wherein the at least one step is a decision related to the user's state of health. 
     
     
         9 . The method of  claim 1 , wherein the at least one predetermined target level of interaction is adjusted by an authorized user. 
     
     
         10 . The method of  claim 1 , further comprising adjusting the at least one predetermined target level of interaction according to a time of day. 
     
     
         11 . The method of  claim 1 , further comprising adjusting the at least one predetermined target level of interaction according to a type of activity. 
     
     
         12 . The method of  claim 1 , further comprising adjusting the at least one predetermined target level of interaction according to a future analyte level of the user, predicted using rate of change data. 
     
     
         13 . The method of  claim 1 , further comprising recording a history of the user's actual frequency of interaction with the medical device. 
     
     
         14 . The method of  claim 13 , further comprising adjusting the at least one predetermined target level of interaction according to the recorded history. 
     
     
         15 . The method of  claim 13 , further comprising organizing the history of the user's actual frequency of interaction with the medical device according to behavior variables inputted by the user. 
     
     
         16 . The method of  claim 1 , further comprising rewarding the user when the actual frequency of interaction stays above the at least one predetermined level of interaction for a predetermined time. 
     
     
         17 . The method of  claim 1 , further comprising adjusting the at least one predetermined target level of interaction according to a data received from a sensor located on the user. 
     
     
         18 . An analyte monitoring system, comprising:
 a user interactive analyte device to monitor at least one analyte of a user; and   a processor unit coupled to the user interactive device to determine the frequency of user interaction with the analyte monitoring device.   
     
     
         19 . The system of  claim 18 , wherein the user interactive device comprises an in vivo analyte sensor. 
     
     
         20 . The system of  claim 20 , wherein the sensor is configured to at least be partially positioned under a skin surface of a user.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.